Patent ID: 6500625
Filing Date: 2002-12-31
Classification: C07K,C12Q,Y10T

Abstract:
A method for diagnosing cancer or precancer in a patient, which method comprises:(a) detecting the level of heterogenous nuclear ribonucleoprotein (hnRNP) in a test biological sample comprising hnRNP obtained from the patient; and (b) comparing the level of the hnRNP in the test biological sample with the level of hnRNP in a normal sample obtained from the patient or from another source; whereupon a higher level of hnRNP in the test biological sample as compared to the level of hnRNP in the normal sample is indicative of the presence of cancer or precancer in the patient, (b) comparing the level of the hnRNP in the test biological sample with the level of hnRNP in a normal sample obtained from the patient or from another source; whereupon a higher level of hnRNP in the test biological sample as compared to the level of hnRNP in the normal sample is indicative of the presence of cancer or precancer in the patient.